Mark For: MMT® trademark registration is intended to cover the categories of
Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 88235670 |
Registration Number | 1482563 |
Mark Literal Elements | MMT |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2019-10-22 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Christina M. Licursi, Esq. |
Attorney Docket Number | V027920003US |
Law Office Assigned | L40 |
Employee Name | SPILS, CAROL A |
2018-12-19 | Application Filed |
2019-08-27 | Published |
2019-08-27 | Published for Opposition |
2019-10-22 | Location: INTENT TO USE SECTION |
2019-10-22 | Status: Live/Pending |
2019-10-22 | Transaction Date |
2020-10-16 | Status: A second request for extension of time to file a Statement of Use has been granted. |
Party: | ![]() |
Address | 65 Hayden Avenue Lexington, MASSACHUSETTS UNITED STATES 02421 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
![]() | JPEG | 2018-12-19 |
![]() | MULTI | 2018-12-19 |
![]() | XML | 2019-03-19 |
![]() | APPLICATION/XML | 2019-03-19 |
![]() | XML | 2019-03-21 |
![]() | MULTI | 2019-03-22 |
![]() | XML | 2019-06-19 |
![]() | MULTI | 2019-06-28 |
![]() | MULTI | 2019-07-23 |
![]() | XML | 2019-08-07 |
![]() | XML | 2019-08-07 |
![]() | APPLICATION/XML | 2019-08-27 |
![]() | XML | 2019-10-22 |
![]() | MULTI | 2020-04-21 |
![]() | XML | 2020-04-23 |
![]() | MULTI | 2020-04-23 |
![]() | XML | 2020-10-16 |
![]() | XML | 2020-10-20 |
![]() | APPLICATION/XML,IMAGE/JPEG | 2020-10-20 |
IC 005. US 006 018 044 046 051 052. G & S: therapeutic pharmaceuticals for medical use for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders, obesity, and diabetes in humans; dietetic foods adapted for medical use; dietary supplements; nutritional supplements; nutraceuticals for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders, obesity, and diabetes in humans; medical diagnostic reagents and assays for testing body fluids for microorganisms for modifying the microbial composition or metabolic output of the human microbiome
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | therapeutic pharmaceuticals for medical use for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders, obesity, and diabetes in humans; dietetic foods adapted for medical use; dietary supplements; nutritional supplements; nutraceuticals for the treatment of dysbiosis, infectious diseases, inflammatory diseases, cancer, gastro-intestinal diseases, metabolic diseases and disorders, cardiovascular diseases and disorders, immune disorders, kidney diseases and disorders, liver diseases and disorders, organ failure, autoimmune diseases, brain conditions, genetic disorders, drug-induced toxicities, allergies, depression, autism spectrum disorders, obesity, and diabetes in humans; medical diagnostic reagents and assays for testing body fluids for microorganisms for modifying the microbial composition or metabolic output of the human microbiome |
Description | Date | Proceeding Number |
---|---|---|
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-10-20 | |
TEAS EXTENSION RECEIVED | 2020-10-16 | |
EXTENSION 2 GRANTED | 2020-10-16 | 98765 |
EXTENSION 2 FILED | 2020-10-16 | 98765 |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-04-23 | |
TEAS EXTENSION RECEIVED | 2020-04-21 | |
EXTENSION 1 GRANTED | 2020-04-21 | 98765 |
EXTENSION 1 FILED | 2020-04-21 | 98765 |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-10-22 | |
PUBLISHED FOR OPPOSITION | 2019-08-27 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-08-27 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-08-07 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-07-20 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-06-27 | 73296 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-06-27 | 73296 |
ASSIGNED TO LIE | 2019-06-25 | 73296 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-06-19 | |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-03-22 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-03-22 | 74307 |
NON-FINAL ACTION E-MAILED | 2019-03-22 | 6325 |
ASSIGNED TO EXAMINER | 2019-03-14 | 74307 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-01-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.